The effect of Lipo prostaglandin E1 on cauda equina blood flow in patients with lumbar spinal canal stenosis: Myeloscopic observation

Spinal Cord

Volumn 37, Issue 4, 1999, Pages 269-274

  Yone, K ^a   Sakou, T ^b   Kawauchi, Y ^b  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b NONE

Author keywords

Cauda equina; Intermittent claudication; Lipo prostaglandin E1; Lumbar spinal canal stenosis; Myeloscopy

Indexed keywords

ALPROSTAGIL; LIPOPROSTAGLANDIN E1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD FLOW; CAUDA EQUINA; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFECT; FEMALE; HUMAN; HYPOTENSION; INTERMITTENT CLAUDICATION; JAPAN; LEG; MALE; PAIN; PARESTHESIA; PRIORITY JOURNAL; VASODILATATION; VERTEBRAL CANAL STENOSIS;

EID: 0032959196     PISSN: 13624393     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.sc.3100780     Document Type: Article

References (19)

1. 1 Verbiest H. A radicular syndrome from developmental narrowing of the lumbar vertebral canal. J Bone Joint Surg 1954; 36B: 230-237.
2. 2 Blau JN, Rushworth G. Observation on the blood vessels of the spinal cord and their responses to motor activity. Brain 1958; 81: 354-363.
3. 3 Evans JG. Neurogenic intermittent claudication. Br Med J 1964; 2: 985-987.
4. 4 Kavanaugh GJ, Svien HJ, Holman CB, Johnson RM. 'Pseudoclaudication' syndrome produced by compression of the cauda equina. JAMA 1968; 206: 2477-2481.
5. 5 Olmarker K, Rydevik B, Holm S. Edema formation in spinal nerve roots induced by experimental, graded compression. Spine 1989; 14: 569-573.
6. 6 Ooi Y, Mita F, Satoh Y. Myeloscopic study on lumbar spinal canal stenosis with special reference to intermittent claudication. Spine 1990; 15: 544-549.
7. 7 Tsuji H et al. Redundant nerve root in patients with degenerative lumbar spinal stenosis. Spine 1985; 10: 72-82.
8. 8 Wilson CB. Significance of the small lumbar spinal canal: cauda equina compression syndrome due to spondylosis. Part 3: intermittent claudication. J Neurosurg 1969; 31: 499-506.
9. 9 Murakami M et al. Effects of intravenous administration of Lipo PGE1 for lumbar spinal canal stenosis. Rinsho Seikei Geka 1992; 27: 1011-1018 (in Japanese).
10. 10 Ono K, Miura S, Tuji H, Kataoka O. Clinical assessment of PGE1 formation for lumbar spinal canal stenosis. Spin & Spinal Cord 1997; 10: 517-524 (in Japanese).
11. 1. Br Med J 1980; 281: 1031-1034.
12. 1 infusions for vascular insufficiency in progressive systemic sclerosis. Ann Rheum Dis 1981; 40: 350-354.
13. 13 Kawauchi Y, Yone K, Sakou T. Myeloscopic observation of adhesive arachnoiditis in patients with lumbar spinal stenosis. Spinal Cord 1996; 34: 403-410.
14. 14 Mizushima Y, Yanagawa A, Hoshi K. Prostaglandin E1 is more effective, when incorporated in lipid microsheres, for treatment of peripheral vascular diseases in man. J Pharm Pharmacol 1983; 35: 667-668.
15. 15 Japanese Orthopaedic Association Committe. Assessment of treatment of low back pain. J Jpn Orthop Ass 1984; 58: 952-955.
16. 16 Edgar MA. The pathogenesis of low back pain and leg pain. In: Nixon JE (ed). Spinal stenosis. Edward Arnold: London 1991, pp 36-54.
17. 1 in the human pulmonary circulation. Surgery 1977; 81: 716-722.
18. 18 Hallberg D. Elimination of exogenous lipids from the blood stream. Acta Physiol 1965; 254: 1-23.
19. 19 Mizushima Y, Yanagawa T, Yokoyama K. Tissue distribution and anti-inflammatory activity of corticosteroids incorporated in lipid emulsion. Ann Rheum Dis 1982; 41: 263-267.